Pages that link to "Q24568136"
Jump to navigation
Jump to search
The following pages link to Neutrophil-to-lymphocyte ratio for predicting palliative chemotherapy outcomes in advanced pancreatic cancer patients (Q24568136):
Displaying 50 items.
- Nanovectors for anti-cancer drug delivery in the treatment of advanced pancreatic adenocarcinoma (Q28077206) (← links)
- Prognostic significance of neutrophil to lymphocyte ratio in pancreatic cancer: a meta-analysis (Q28083684) (← links)
- Neutrophil-to-lymphocyte ratio as prognostic indicator in gastrointestinal cancers: a systematic review and meta-analysis (Q33762053) (← links)
- Pretreatment C-reactive protein to albumin ratio for predicting overall survival in advanced pancreatic cancer patients (Q33774197) (← links)
- Preoperative lymphocyte-to-monocyte ratio predicts clinical outcome in patients undergoing radical cystectomy for transitional cell carcinoma of the bladder: a retrospective analysis (Q34226276) (← links)
- Prognostic role of the neutrophil-to-lymphocyte ratio in pancreatic cancer: a meta-analysis (Q35905788) (← links)
- Pretreatment neutrophil-to-lymphocyte ratio predicts the prognosis in patients with metastatic prostate cancer (Q35925423) (← links)
- A prognostic index model to predict the clinical outcomes for advanced pancreatic cancer patients following palliative chemotherapy (Q35946922) (← links)
- Prognostic significance of the lymphocyte-to-monocyte ratio in patients with metastatic colorectal cancer (Q36050510) (← links)
- Increased neutrophil-to-lymphocyte ratio is associated with disease-specific mortality in patients with penile cancer (Q36069609) (← links)
- Neutrophil-to-Lymphocyte Ratio for Predicting Loss of Response to Infliximab in Ulcerative Colitis (Q36246295) (← links)
- Neutrophil-to-lymphocyte ratio predicts prostatic carcinoma in men undergoing needle biopsy (Q36544801) (← links)
- Neutrophil-to-lymphocyte ratio is a prognostic marker in bladder cancer patients after radical cystectomy (Q36654421) (← links)
- Prognostic value of inflammation-based markers in patients with pancreatic cancer administered gemcitabine and erlotinib (Q37089422) (← links)
- Pretreatment Neutrophil-to-Lymphocyte Ratio Can Predict the Prognosis in Bladder Cancer Patients Who Receive Gemcitabine and Nedaplatin Therapy (Q37378328) (← links)
- Preoperative evaluation of pancreatic ductal adenocarcinoma with synchronous liver metastasis: Diagnosis and assessment of unresectability (Q37483443) (← links)
- Performance status and neutrophil-lymphocyte ratio are important prognostic factors in elderly patients with unresectable pancreatic cancer (Q37525286) (← links)
- Neutrophils assist the metastasis of circulating tumor cells in pancreatic ductal adenocarcinoma: A new hypothesis and a new predictor for distant metastasis (Q37605852) (← links)
- Predictive biomarkers for the efficacy of peptide vaccine treatment: based on the results of a phase II study on advanced pancreatic cancer. (Q37671162) (← links)
- Preoperative neutrophil-to-lymphocyte ratio and tumor-related factors to predict lymph node metastasis in patients with pancreatic ductal adenocarcinoma (PDAC) (Q37687561) (← links)
- Atrial Fibrillation is Strongly Associated With the Neutrophil to Lymphocyte Ratio in Acute Ischemic Stroke Patients: A Retrospective Study. (Q38411287) (← links)
- Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio are predictive of chemotherapeutic response and prognosis in epithelial ovarian cancer patients treated with platinum-based chemotherapy (Q38763938) (← links)
- Neutrophil/lymphocyte ratio helps select metastatic pancreatic cancer patients benefitting from oxaliplatin (Q40502145) (← links)
- Prognostic model for survival based on readily available pretreatment factors in patients with advanced pancreatic cancer receiving palliative chemotherapy. (Q40784520) (← links)
- Neutrophil-to-Lymphocyte Ratio Predicts Prognosis in Castration-Resistant Prostate Cancer Patients Who Received Cabazitaxel Chemotherapy (Q41691026) (← links)
- Preoperative neutrophil-to-lymphocyte ratio predicts response to first-line platinum-based chemotherapy and prognosis in serous ovarian cancer (Q44882899) (← links)
- Neutrophil-to-lymphocyte ratio: Prognostic indicator for head and neck squamous cell carcinoma. (Q45934145) (← links)
- Prognostic value of systemic inflammation score in patients with hepatocellular carcinoma after hepatectomy (Q46838204) (← links)
- Survival prediction in pancreatic cancer patients with no distant metastasis: a large-scale population-based estimate (Q47332749) (← links)
- Prognostic value of postdiagnostic inflammation-based scores in short-term overall survival of advanced pancreatic ductal adenocarcinoma patients (Q49487440) (← links)
- Prognostic role of platelet to lymphocyte ratio in pancreatic cancers: A meta-analysis including 3028 patients (Q49712241) (← links)
- The Significance of the Prognostic Nutritional Index for All Stages of Pancreatic Cancer (Q51266754) (← links)
- Consensus statement on mandatory measurements in pancreatic cancer trials (COMM-PACT) for systemic treatment of unresectable disease. (Q52672325) (← links)
- Neutrophil-lymphocyte and platelet-lymphocyte ratio in patients after resection for hepato-pancreatico-biliary malignancies. (Q53548609) (← links)
- Prognostic Roles of Inflammatory Markers in Pancreatic Cancer: Comparison between the Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio. (Q55441827) (← links)
- Neutrophil to lymphocyte ratio predicts island sign in patients with intracranial hemorrhage (Q58083301) (← links)
- Evaluation of inflammation-based markers for predicting the prognosis of unresectable pancreatic ductal adenocarcinoma treated with chemotherapy (Q58788893) (← links)
- Severe Neutropenia is Associated with Better Clinical Outcomes in Patients with Advanced Pancreatic Cancer Who Receive Modified FOLFIRINOX Therapy (Q59797795) (← links)
- The Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Head and Neck Cancer Patients Treated with Radiotherapy (Q60920889) (← links)
- Predicting mortality and adverse events in patients with advanced pancreatic cancer treated with palliative gemcitabine-based chemotherapy in a multicentre phase III randomized clinical trial: the APC-SAKK risk scores (Q60922380) (← links)
- Outcome of head compared to body and tail pancreatic cancer: a systematic review and meta-analysis of 93 studies (Q64094461) (← links)
- Advances in pancreatic cancer biomarkers (Q64233995) (← links)
- Minimum absolute lymphocyte count during radiotherapy as a new prognostic factor for nasopharyngeal cancer (Q85289965) (← links)
- THE ROLE OF IMMUNOINFLAMMATORY MARKERS IN THE PROGNOSIS AND RESECTABILITY OF PANCREATIC ADENOCARCINOMA (Q89418180) (← links)
- The Role of Neutrophil-to-lymphocyte Ratio on the Effect of CRT for Patients With Rectal Cancer (Q89947440) (← links)
- FOLFIRINOX in patients with peritoneal carcinomatosis from pancreatic adenocarcinoma: a retrospective study (Q90244152) (← links)
- Association of Neutrophil to Lymphocyte Ratio on 90-Day Functional Outcome in Patients with Intracerebral Hemorrhage Undergoing Surgical Treatment (Q90919190) (← links)
- Preoperative neutrophil lymphocyte ratio but not platelet lymphocyte ratio predicts survival and early relapse in patients with oral, pharyngeal, and lip cancer (Q91000559) (← links)
- Pretreatment biomarkers as prognostic predictors of survival in patients with Pancreatic Cancer treated with Gemcitabine-based Therapy and 5-Fluorouracil: Neutrophil-to-lymphocyte ratio vs Platelet-to-lymphocyte ratio (Q97094020) (← links)
- Implementing biological markers as a tool to guide clinical care of patients with pancreatic cancer (Q103038645) (← links)